1.Calcium/Calmodulin-dependent Protein Kinase-II δ Involved in Doxorubicin Induced Cardio-toxicity in Experimental Rats
Yao QIN ; Hongyan ZHAO ; Wenhang ZHANG ; Dongmei WANG
Chinese Circulation Journal 2015;(10):1004-1007
Objective: To explore the role of calcium/calmodulin-dependent protein kinase-II δ (CaMK-II δ) in doxorubicin (DOX) induced cardio-toxicity in experimental rats.
Methods:①The rat’s cardiomyocytes were treated by DOX and the cell proliferation, protein expression and activity of CaMK-II δ were examined.②CaMK-II δ gene was knocked out by CRISPR method, the changes of DOX induced cell apoptosis and NF-κb activity and miR-146a expression were detected.
Results: DOX could inhibit cardiomyocyte proliferation, the protein expression level of CaMK-II δ was similar and the activity was increased. CRISPR method may effectively knock out CaMK-II δ gene. Compared with normal cells, the cells from CaMK-II δ knocked out rats had decreased sensitivity to DOX induction, suppressed NF-κb activation and miR-146a up-regulation.
Conclusion: CaMK-II δ participated in DOX induced cardio-toxicity in experimental rats and NF-κb and miR-146a were involved in this process.
2. Retrospective cohort study on subtotal colonic bypass plus colostomy with antiperistaltic cecoproctostomy in the treatment of senile slow transit constipation
Yang YANG ; Yongli CAO ; Wenhang WANG ; Yuanyao ZHANG ; Nan ZHAO ; Dong WEI
Chinese Journal of Gastrointestinal Surgery 2019;22(4):370-376
Objective:
To investigate the clinical efficacy of laparoscopic subtotal colonic bypass plus colostomy with antiperistaltic cecoproctostomy (SCBCAC) in the treatment of senile slow transit constipation.
Methods:
A retrospective cohort study was performed. Clinical data of 30 colonic slow transit constipation patients aged ≥70 years old undergoing laparoscopic SCBCAC from July 2012 to October 2016 (bypass plus colostomy group), and 28 patients undergoing laparoscopic subtotal colonic bypass with antiperistaltic cecoproctostomy (SCBAC) from February 2009 to June 2012 (bypass group) at our institute were collected. Efficacy was compared between the two procedures. Inclusion criteria: (1) meeting the Rome III diagnosis criteria for constipation; (2) confirmed diagnosis of slow transit constipation; (3) age ≥ 70 years old; (4) receiving non-surgical treatment for more than 5 years, and Wexner constipation score > 15; (5) follow-up for more than 2 years. Those with psychiatric symptoms or previous psychiatric history, obvious signs of outlet obstructive constipation, organic diseases of the colon and life-threatening cardiovascular diseases or cancer were excluded. In the bypass plus colostomy group, laparoscopy was performed via five trocars. The ileocecal junction and the ascending colon were mobilized and the ileocecal junction was pulled down to the pelvic inlet. The ascending colon was transected and the appendix was excised. The lateral peritoneum of the sigmoid colon and the rectal mesentery were dissected and the upper rectum was transected. The avil of a circular stapler was placed in the bottom of the cecum. The shaft of the stapler was placed in the rectum via the anal canal to complete end-to-side anastomosis (end rectum to lateral cecum). The end of the rectal-sigmoid colon was used for colostomy via an extraperitoneal approach to complete the operation. The following efficacy indexes were collected before surgery and 3, 6, 12, and 24 months after surgery: the number of daily bowel movements, the Wexner incontinence scale (WIS, 0-20, the lower the better), the Wexner constipation scale (WCS, 0-30, the lower the better), the gastrointestinal quality of life index (GIQLI, 0-144, the higher score, the better), abdominal pain intensity indicated by the numerical rating scale (NRS, 0-10, the lower score, the better), and the abdominal bloating score (ABS, 0-4, the lower score, the better). The complications defined as Clavien-Dindo class II or above were observed and recorded.
Results:
No significant differences in preoperative WCS, WIS, GIQLI, NRS, and ABS were observed between bypass plus colostomy group and bypass group (all
3.The value of ultraGlarge pitch Turbo Flash scan mode in the diagnosis of tracheal foreign body in infants
Hui SONG ; Wenhang LI ; Ying TANG ; Rongpin WANG ; Lei TANG ; Denghua CAI ; Xianchun ZENG
Journal of Practical Radiology 2019;35(10):1661-1664
Objective To explore the value of ultra-large pitch Turbo Flash scan mode in the diagnosis of tracheal foreign body in infants.Methods The imaging data of 60 infants with foreign body in trachea confirmed by bronchus endoscopy were analyzed retrospectively. The 60 infants were equally divided into 2 groups according to the scanning time.For group A,the routine scan with the mode of CARE Dose 4D/CARE kV and pitch as 1.9 was performed.For group B,the scan with ultra-large pitch Turbo Flash model was performed.The scanning time,volume CT dose index (CTDIvol)and dose length product (DLP)of each patient were recorded in both groups and statistically analyzed.Results The scanning time,DLP and CTDIvol of group A and group B were statistically significant.CTDIvol and DLP of group B were significantly lower than those of group A (P<0.05).The diagnostic accuracy of group A and B were 100%(30/30),respectively (P>0.05).The foreign body display of group A and B were 100% (30/30),respectively (P>0.05).Conclusion Ultra-large pitch Turbo Flash can be used to detect tracheal foreign body in infants.It can significantly reduce radiation dose,shorten examination time and obtain satisfactory image quality.
4.Effect of hemX gene deletion on heme synthesis in Bacillus amyloliquefaciens.
Jiameng LIU ; Yexue LIU ; Chenxu ZHAO ; Wenhang WANG ; Qinggang LI ; Fuping LU ; Yu LI
Chinese Journal of Biotechnology 2023;39(3):1119-1130
Heme, which exists widely in living organisms, is a porphyrin compound with a variety of physiological functions. Bacillus amyloliquefaciens is an important industrial strain with the characteristics of easy cultivation and strong ability for expression and secretion of proteins. In order to screen the optimal starting strain for heme synthesis, the laboratory preserved strains were screened with and without addition of 5-aminolevulinic acid (ALA). There was no significant difference in the heme production of strains BA, BAΔ6 and BAΔ6ΔsigF. However, upon addition of ALA, the heme titer and specific heme production of strain BAΔ6ΔsigF were the highest, reaching 200.77 μmol/L and 615.70 μmol/(L·g DCW), respectively. Subsequently, the hemX gene (encoding the cytochrome assembly protein HemX) of strain BAΔ6ΔsigF was knocked out to explore its role in heme synthesis. It was found that the fermentation broth of the knockout strain turned red, while the growth was not significantly affected. The highest ALA concentration in flask fermentation reached 82.13 mg/L at 12 h, which was slightly higher than that of the control 75.11 mg/L. When ALA was not added, the heme titer and specific heme production were 1.99 times and 1.45 times that of the control, respectively. After adding ALA, the heme titer and specific heme production were 2.08 times and 1.72 times higher than that of the control, respectively. Real-time quantitative fluorescent PCR showed that the expressions of hemA, hemL, hemB, hemC, hemD, and hemQ genes at transcription level were up-regulated. We demonstrated that deletion of hemX gene can improve the production of heme, which may facilitate future development of heme-producing strain.
Gene Deletion
;
Bacillus amyloliquefaciens/metabolism*
;
Aminolevulinic Acid/metabolism*
;
Heme/metabolism*
;
Fermentation